Lucy Scientific Discovery

Historical price data

Lucy Scientific Discovery is a publicly traded Canadian biotech company with a mission to be a foundational supplier and research partner in the emerging psychedelic and psychotropic pharmaceutical industry. Its core strategy is built on its regulatory authorization to handle controlled substances, enabling a business model focused on contract manufacturing of APIs and contract research services. The company aims to generate near-term service revenue while supporting the broader ecosystem's development of novel therapeutics, though it remains in a pre-revenue, early-stage operational phase.

The company's platform is its regulatory authorization from Health Canada, enabling the legal handling, manufacturing, and research of controlled psychedelic and cannabinoid substances for pharmaceutical supply and contract research services.

Lucy competes with a small set of other licensed dealers and specialized API manufacturers in Canada. Its primary advantage is its early regulatory status, but it faces potential competition from larger, well-capitalized contract manufacturing organizations (CDMOs) that may enter the space as it matures.